CLPT Clearpoint Neuro Inc
Company Analysis
Latest News
🔴 Clearpoint Neuro is trading 20.2% down today after Q2 earnings miss, revenue miss, and guidance cut
Clearpoint Neuro is trading 20.2% down at $12.28 after reporting Q2 results that missed both revenue and earnings estimates and included a full-year 2026...
ClearPoint Neuro's second quarter revenue grew 18% to $10.9M, but the company lowered its full-year 2026 guidance.
ClearPoint Neuro reported second quarter revenue of $10.9 million, an 18% increase year-over-year, which beat analyst estimates of $10.45 million. The company...
Clearpoint Neuro Inc Q2 2026 Earnings Preview: What Analysts Expect on August 03, 2026
Clearpoint Neuro is expected to report a Q2 loss of $0.29 per share on consensus revenue of $10.45 million, with the current stock price of $9.45 trading...
🔴 Clearpoint Neuro is trading 5.3% down today with no clear company-specific catalyst found
Clearpoint Neuro is trading at $14.14 (-5.33%) in after-hours trading with no clear company-specific catalyst found to explain the move from its regular...
🟢 Clearpoint Neuro is trading 5.9% up today amid broader market tailwinds
Clearpoint Neuro is trading 5.9% up at $14.95 in pre-market as broader market tailwinds and a strong risk-on tone lift equities. • The stock is rebounding...
🟢 Clearpoint Neuro is trading 5.6% up today in an isolated rebound after recent declines
Clearpoint Neuro is trading at $15.90 (5.6% up) as the stock stages an isolated rebound following a volatile week characterized by several consecutive...
🔴 Clearpoint Neuro is trading 5.2% down today amid risk-off sentiment in small-cap healthcare
Clearpoint Neuro is trading at $16.59 (5.2% down) today as the stock faces pressure from broader market weakness and a shift away from high-growth, loss-making...
🔴 Clearpoint Neuro is trading 5.6% down today amid broader market weakness and soft tech sentiment
Clearpoint Neuro is trading at $16.88 (-5.58%) in pre-market sessions as broader market weakness and uneven technology sentiment weigh on small-cap healthcare...
🟢 CLPT is trading 5.8% up today on continued momentum from uniQure Huntington’s therapy progress
CLPT is trading 5.8% up at $18.50 in pre-market, extending gains driven by its partnership with uniQure on a Huntington’s disease gene therapy. • The strength...
🔴 CLPT is trading 5.1% down today on regulatory uncertainty and weak revenue guidance
CLPT is trading 5.1% down at $17.76 in pre-market, pulling back after a recent rebound and ongoing volatility. • The stock has faced pressure in 2026 stemming...
🟢 CLPT is trading 5% up today in a rebound following recent volatility
CLPT is trading 5% up at $18.74 as the stock appears to be rebounding following a period of significant price swings. • The move follows a sharp 8.2% decline...
🟢 CLPT makes sharp 10.6% jump
CLPT is trading at $18.86, up 10.6% versus the comparison close of $17.06 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 CLPT is trading 5.8% up today as Huntington’s gene therapy data fuels extended rally
CLPT is trading at $18.05 (5.8% up), extending a sharp rally triggered by positive three-year Phase I/II data for the AMT-130 Huntington’s disease gene therapy...
🟢 Clearpoint Neuro Inc makes sharp 10.6% jump
CLPT is trading at $18.60, up 10.6% versus the comparison close of $16.81 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Clearpoint Neuro Inc is trading 7% up today following positive FDA feedback for partner uniQure
Clearpoint Neuro Inc is trading 7% up today at $17.98, extending a powerful two-day rally driven by optimism surrounding partner uniQure’s Huntington’s disease...
🟢 Clearpoint Neuro Inc surges 29.7% as UniQure's FDA progress highlights platform value
Clearpoint Neuro Inc is trading at $17.30 (+29.65%) today after its partner UniQure announced positive FDA feedback for its Huntington's disease therapy,...
🟢 Clearpoint Neuro Inc is trading 27.8% up today on thin pre-market liquidity and speculative interest
Clearpoint Neuro Inc is trading 27.8% up today at $17.04 amid unusually strong pre-market buying interest following a period of flat-to-lower trading. • The...
🔴 Clearpoint Neuro Inc is trading 5.3% down today with no clear company-specific catalyst found
Clearpoint Neuro Inc is trading at $13.11 (-5.26%) following a sharp intraday selloff without a confirmed company-specific catalyst to explain the move. • The...
🟢 Clearpoint Neuro Inc is trading 5% up today in a technical rebound after a sharp decline
Clearpoint Neuro Inc is trading 5% up today at $13.54 in what appears to be a technical rebound following a sharp decline in the prior session. * The move...
🟢 Clearpoint Neuro Inc is trading 5.9% up today in a technical rebound after a recent sell-off
Clearpoint Neuro Inc is trading 5.9% up at $13.65 in pre-market hours, staging a technical rebound following a sharp decline in the previous session. • The...